Xu, Junyu
Zhao, Nan
Huang, Jie
Li, Jinlei
Zhao, Xia
Xiang, Qian
Yang, Sibo
Dong, Yanli
Wang, Honghui
Li, Yijing
Yang, Guoping
Cui, Yimin https://orcid.org/0000-0002-4186-1005
Funding for this research was provided by:
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Article History
Accepted: 29 May 2023
First Online: 16 June 2023
Declarations
:
: The study was funded by Jiangsu Hengrui Pharmaceuticals Co., Ltd.
: Yanli Dong, Honghui Wang and Yijing Li are employees of Jiangsu Hengrui Pharmaceuticals Co., Ltd. No potential conflict of interest was reported by the other authors.
: The study protocol and informed consent forms were approved by the Institutional Review Board of Peking University First Hospital and the Third Xiangya Hospital.
: Informed consents were obtained from all individual participants included in the study.
: The informed consent form included a disclaimer that data will be anonymized and published.
: The data are not available in a repository but will be provided upon request to the corresponding author on reasonable request.
: Not applicable.
: Junyu Xu, Nan Zhao, Jie Huang, Jinlei Li, Xia Zhao, Qian Xiang, Sibo Yang, Yanli Dong, Honghui Wang and Yijing Li contributed to the study design and the analysis and interpretation of data. Yimin Cui and Guoping Yang were principal investigators and was responsible for the design and conduct of the study, and the reporting of data. All authors were involved in critically revising the manuscript for important intellectual content and approved the final version.